Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
about
Intravitreal steroids for macular edema in diabetesThe combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implantClinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part IIUpdate on corticosteroids for diabetic macular edemaIntravitreal bevacizumab alone versus combined with macular photocoagulation in diabetic macular edemaEfficacy of intravitreal triamcinolone acetonide for eyes with postvitrectomy diabetic vitreous hemorrhage.Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case seriesSubthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema.Clinical trials on corticosteroids for diabetic macular edemaDiffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.Relationship between foveal birefringence and visual acuity in neovascular age-related macular degeneration.The effect of posterior subtenon methylprednisolone acetate in the refractory diabetic macular edema: a prospective nonrandomized interventional case series.Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.Pharmacotherapies for diabetic retinopathy: present and future.Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcomeIntravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.Resource use and costs associated with diabetic macular edema in elderly persons.Comparison of combination posterior sub-tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema.Intravitreal bevacizumab for treatment of diabetic macular edemaComparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.Intraocular soluble intracellular adhesion molecule-1 correlates with subretinal fluid height of diabetic macular edema.Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbiditiesIntravitreal triamcinolone reinjection for refractory diabetic macular edema.Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot studyDiabetic macular edema: therapeutic options.Comparison of natural course, intravitreal triamcinolone and macular laser photocoagulation for treatment of mild diabetic macular edema.Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study.Recent advances in ophthalmic drug delivery.Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema.Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1).Intravitreal triamcinolone acetonide for exudative age related macular degeneration.Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.Intraocular pressure alterations following intravitreal triamcinolone acetonide.A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eyeInflammatory cytokines in aqueous humor of patients with choroidal neovascularization.
P2860
Q24242456-3A2B1F27-B873-4E26-A127-75BF0657DEEDQ24810825-67C4AE75-1E37-409C-83A6-39E7118EB8EBQ26775853-B1368FE9-7B8C-40C2-811C-0C2EC4E77083Q26864721-B0DEF794-9407-449C-8B12-8DDC874D2FE8Q28074846-48B0FE62-0A99-4517-8B9E-4EBD7B846BD5Q30473844-C551D1E8-FF6F-4520-AF31-0485B2C04AF8Q30491121-2C35EE47-1540-4E5F-BAD1-5B43F0B902A7Q31095625-6A666C88-8E64-402A-8219-296F168E46A8Q31136758-4EFDB61A-05F4-44A1-A169-142D54000044Q31146864-B7FA6E0A-FF52-4459-8082-0B9D28659297Q31148660-44E44944-C1F5-47CB-89DE-5B10EF980B81Q33206078-46F694B5-DF14-46FD-9456-CF948735091BQ33231055-006F2EF9-6CBC-4D7F-8AC6-AF97830AA396Q33238893-C81EBB3B-5CE1-42F0-ADA4-8C8D8D2BA697Q33282848-F5FC9EC9-B63B-4BF1-BC28-90CFF10032B6Q33294882-AFA22DED-195F-46C5-B719-811F9B9455D2Q33297474-31B640EE-193F-44A2-993F-158A090723D8Q33325652-F945EF68-CDFA-434D-9F40-37DAC21417A8Q33390920-3A1156E6-9CA1-41AF-9CCF-9CEACAF57B21Q33395775-F7A10FC6-8D9B-41A8-8445-13C71CF48C1CQ33425236-09D60043-D7DF-49F4-B5E1-D2C0DBE1B912Q33507910-7E4BF80E-C4B0-41C9-8256-FF0CDC2DDE21Q33771458-0260FD43-0BDE-4E6D-911E-26432E580C73Q34000099-A7E0D81F-1678-4FC6-97C2-AC6781A21EF3Q34014971-BC467C74-30CD-4CAA-93EC-2A5D74D7E79DQ34082086-BA640623-99F3-40E5-999B-02AC00258437Q34185374-B7D9F240-CE52-43D3-88C6-AD1CE7DA0CFFQ34570768-9C1228C5-CF68-40D0-9010-AEDFF77E0CD3Q34601246-D6F200BC-13B0-4EED-B214-E4C0CB6B5F99Q34636338-7009B19D-9E0C-46A7-9651-B5AD270FF861Q34705556-8E2C9474-FC6F-4BFB-9FE0-0611FE82C610Q34758061-D77A53C6-0428-4F2C-979D-25B10E44120DQ35009731-CF1D2145-4FE8-407D-B94A-C7DF5883B627Q35079688-B4DD703F-4037-4442-AC5E-40581E13C2B2Q35590749-6C134E66-236D-44DF-AE46-5E0FB86C6260Q35592674-D7194A13-0F58-4803-89DD-CBE558A4BFB4Q35762005-8AB2F69A-326B-435E-AB22-BBEF746DED41Q35762992-2BF85521-14D4-490B-A62F-32D100D91B0EQ35769376-7291CE4A-04C0-4E9D-96C9-1A8A413A0FC0Q35818087-D316FB30-F809-458F-9C56-AEAB7B5C68DD
P2860
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
@ast
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
@en
type
label
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
@ast
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
@en
prefLabel
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
@ast
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
@en
P2093
P1433
P1476
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
@en
P2093
Antje Söfker
Ingrid Kreissig
Robert F Degenring
P356
10.1001/ARCHOPHT.121.11.1663-B
P407
P50
P577
2003-01-01T00:00:00Z